查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1455680

精准肿瘤市场，按产品类型、按适应症类型、最终用途、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Precision Oncology Market, By Product Type, By Indication Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 323 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年精准肿瘤市场规模为695.8467亿美元，2024年至2032年复合CAGR为11.2%。

精准肿瘤市场-市场动态

技术进步推动市场需求

市场成长的主要驱动力包括技术进步、对提供有效临床结果的诊断产品不断增长的需求，从而最大限度地减少治疗副作用并防止抗药性。同样，不断扩大的研究活动、乳癌的早期检测以及患者的整体预后都将增强对精准肿瘤学的需求。由于全球范围内的社交距离措施和封锁，COVID-19 大流行已经影响了精准肿瘤学市场。此外，在大流行初期，临床试验研究暂时停止。然而，大流行后，医院和诊所进行精准肿瘤学分析和治疗的患者流量下降。使用精准肿瘤学的延迟诊断和治疗严重影响了癌症患者的照护。

精准肿瘤学市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 11.2% 左右的CAGR成长

根据产品类型细分，预计治疗药物将在 2023 年显示最大的市场份额

根据适应症类型细分，乳癌是2023年的主要类型

按地区划分，北美是 2023 年的主要收入来源

精准肿瘤学市场-細項分析：

全球精准肿瘤学市场根据产品类型、适应症类型、最终用途和地区进行细分。

根据产品类型，市场分为两类：诊断和治疗。 2023年，在肿瘤不可知治疗的批准数量不断增加以及针对驱动癌症生长的特定蛋白质或突变的治疗的独特特征等因素的推动下，治疗领域成为市场领导者。基于精准肿瘤学的治疗根据个别患者癌症的 DNA 指纹提供针对患者的特定癌症治疗。

依适应症类型将市场分为六类：乳癌、大肠癌、子宫颈癌、肺癌、摄护腺癌等。 2023 年，由于人们越来越关注乳癌筛检、诊断以及手术和放射技术的进步，乳癌占据了最大的市场份额。此外，扩大研究工作、乳癌的早期检测和改善患者预后预计将推动精准肿瘤学等新方法的发展。此外，先进的 DNA 定序技术的出现迅速推进了乳癌患者的治疗。

精准肿瘤学市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

精准肿瘤学市场-竞争格局：

在市场上，专门从事精准肿瘤学的公司专注于创新诊断工具、分子分析技术和标靶治疗，以优化癌症治疗结果。他们将资源分配给研究和开发工作，旨在识别与不同癌症类型相关的生物标记和基因突变，从而实现更准确的诊断和治疗选择。此外，这些公司可以向医疗保健提供者提供全面的基因组分析服务，使他们能够根据患者肿瘤的分子特征做出明智的治疗决策。此外，行销活动旨在提高肿瘤学家、医疗保健提供者和患者对精准肿瘤学在提高治疗效果、最大限度地减少不良反应并最终改善患者预后方面的好处的认识。精准肿瘤学领域的市场参与者正在采取各种创新策略，例如协议、新产品发布和扩张，以增强其市场占有率。

最近的发展：

2021 年 12 月，ConcertAI, LLC 与 LabCorp 宣布合作，旨在加强精准肿瘤学研究。这些公司正在合作进行临床研究，以减轻医生实践的负担并提高患者保留率，从而确保公平地获得研究作为护理选择并推动患者招募。

目录

第一章：精准肿瘤学市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的精准肿瘤学市场片段
    • 按适应症类型分類的精准肿瘤学市场片段
    • 按最终用途分類的精准肿瘤学市场片段
    • 按国家/地区分類的精准肿瘤学市场片段
    • 按地区分類的精准肿瘤学市场片段
  • 竞争洞察

第 3 章：精准肿瘤学主要市场趋势

  • 精准肿瘤学市场驱动因素
    • 市场驱动因素的影响分析
  • 精准肿瘤学市场限制
    • 市场限制影响分析
  • 精准肿瘤学市场机会
  • 精准肿瘤市场未来趋势

第 4 章：精准肿瘤学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：精准肿瘤学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：精准肿瘤学市场格局

  • 2023 年精准肿瘤学市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：精准肿瘤学市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 诊断
    • 疗法

第 8 章：精准肿瘤学市场 - 按适应症类型

  • 概述
    • 按指标类型分類的细分市场占有率分析
    • 乳癌
    • 大肠直肠癌
    • 子宫颈癌
    • 摄护腺癌
    • 肺癌
    • 其他的

第 9 章：精准肿瘤学市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院和诊断实验室
    • 製药与生物技术公司
    • 医疗保健数据公司

第 10 章：精准肿瘤学市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美精准肿瘤学主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模与预测（按适应症类型）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲精准肿瘤学主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按指示类型）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区精准肿瘤主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（依适应症类型）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲精准肿瘤学主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按适应症类型）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲精准肿瘤主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按适应症类型）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：关键供应商分析 - 精准肿瘤学产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Invitae Corporation
    • Qiagen NV
    • Illumina, Inc.
    • Laboratory Corporation Of America Holding
    • Exact Sciences Corporation
    • Rain Oncology Inc.
    • Strata Oncology, Inc.
    • Xilis, Inc.
    • Variantyx, Inc.
    • Bioserve
    • Relay Therapeutics
    • Acrivon Therapeutics
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2343

REPORT HIGHLIGHT

Precision Oncology Market size was valued at USD 69,584.67 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Precision oncology, also referred to as personalized or targeted cancer therapy, represents a tailored approach to cancer treatment, wherein medical interventions such as medications and treatment plans are customized to match the individual characteristics of each patient and their specific cancer subtype. This method considers various factors including the tumor's genetic makeup, molecular profile, and the patient's overall health, aiming to pinpoint the most effective treatment options with minimal side effects.

Precision Oncology Market- Market Dynamics

Technological advancements to propel market demand

Key drivers of market growth include technological advancements, a growing demand for diagnostic products delivering effective clinical results, thereby minimizing therapeutic side effects and preventing drug resistance. Similarly, expanding research activities, early detection of breast cancer, and overall patient prognosis are poised to bolster the demand for precision oncology. The COVID-19 pandemic has impacted the precision oncology market due to social distancing measures and lockdowns worldwide. Additionally, clinical trial studies were temporarily halted during the initial phase of the pandemic. However, post-pandemic, hospitals and clinics have experienced a decline in patient flow for precision oncology analysis along with therapeutic treatment. Delayed diagnosis and treatment using precision oncology have significantly affected cancer patient care.

Precision Oncology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Product Type segmentation, therapeutics was predicted to show maximum market share in the year 2023

Based on Indication Type segmentation, breast cancer was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Precision Oncology Market- Segmentation Analysis:

The Global Precision Oncology Market is segmented on the basis of Product Type, Indication Type, End Use, and Region.

The market is divided into two categories based on Product Type: diagnostics and therapeutics. In 2023, the therapeutics segment emerged as the market leader, propelled by factors such as the increasing amount of approvals for tumor-agnostic treatments and the unique characteristics of therapeutics tailored to specific proteins or mutations driving cancer growth. Precision oncology-based treatments offer patient-specific cancer treatment based on the DNA fingerprint of individually patient's cancer.

The market is divided into six categories based on Indication Type: breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, and others. In 2023, breast cancer held the largest market share, attributed to the growing focus on breast cancer screening, diagnosis, and advancements in surgical and radiation techniques. Additionally, expanding research endeavors, early detection of breast cancer, and improved patient prognosis are expected to drive the development of novel methods like precision oncology. Furthermore, the advent of advanced technologies for DNA sequencing has rapidly advanced the treatment of breast cancer patients.

Precision Oncology Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Precision Oncology Market- Competitive Landscape:

In the marketplace, companies specializing in precision oncology concentrate on innovating diagnostic tools, molecular profiling technologies, and targeted therapies to optimize cancer treatment outcomes. They allocate resources to research and development endeavors aimed at identifying biomarkers and genetic mutations associated with different cancer types, enabling more accurate diagnosis and treatment selection. Additionally, these companies may provide comprehensive genomic profiling services to healthcare providers, empowering them to make informed treatment decisions based on the molecular characteristics of the patient's tumor. Moreover, marketing initiatives seek to raise awareness among oncologists, healthcare providers, and patients regarding the benefits of precision oncology in enhancing treatment efficacy, minimizing adverse effects, and ultimately improving patient outcomes. Market players in the precision oncology sector are engaging in various innovative strategies such as agreements, new product launches, and expansions to bolster their market presence.

Recent Developments:

In December 2021, ConcertAI, LLC, along with LabCorp declared a collaboration aimed at enhancing precision oncology research. These companies are collaborating to launch clinical studies that will alleviate the burden on physician practices and improve patient retention, thereby ensuring equitable access to research as a care option and driving patient recruitment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECISION ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Thermo Fisher Scientific Inc.

Invitae Corporation

Qiagen N.V.

Illumina, Inc.

Laboratory Corporation Of America Holding

Exact Sciences Corporation

Rain Oncology Inc.

Strata Oncology, Inc.

Xilis, Inc.

Variantyx, Inc.

Bioserve

Relay Therapeutics

Acrivon Therapeutics

Others

GLOBAL PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Diagnostics
  • Therapeutics

GLOBAL PRECISION ONCOLOGY MARKET, BY INDICATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Prostate Cancer
  • Lung Cancer
  • Others

GLOBAL PRECISION ONCOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Healthcare Data Companies

GLOBAL PRECISION ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Precision Oncology Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Precision Oncology Market Snippet by Product Type
    • 2.1.2.Precision Oncology Market Snippet by Indication Type
    • 2.1.3.Precision Oncology Market Snippet by End-Use
    • 2.1.4.Precision Oncology Market Snippet by Country
    • 2.1.5.Precision Oncology Market Snippet by Region
  • 2.2.Competitive Insights

3.Precision Oncology Key Market Trends

  • 3.1.Precision Oncology Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Precision Oncology Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Precision Oncology Market Opportunities
  • 3.4.Precision Oncology Market Future Trends

4.Precision Oncology Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Precision Oncology Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Precision Oncology Market Landscape

  • 6.1.Precision Oncology Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Precision Oncology Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Diagnostics
    • 7.1.3.Therapeutics

8.Precision Oncology Market - By Indication Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
    • 8.1.2.Breast Cancer
    • 8.1.3.Colorectal Cancer
    • 8.1.4.Cervical Cancer
    • 8.1.5.Prostate Cancer
    • 8.1.6.Lung Cancer
    • 8.1.7.Others

9.Precision Oncology Market - By End-Use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2.Hospitals & Diagnostic Laboratories
    • 9.1.3.Pharmaceutical & Biotechnology Companies
    • 9.1.4.Healthcare Data Companies

10.Precision Oncology Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Precision Oncology Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Precision Oncology Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Precision Oncology Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Precision Oncology Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Precision Oncology Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Precision Oncology Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Thermo Fisher Scientific Inc.
    • 11.2.2.Invitae Corporation
    • 11.2.3.Qiagen N.V.
    • 11.2.4.Illumina, Inc.
    • 11.2.5.Laboratory Corporation Of America Holding
    • 11.2.6.Exact Sciences Corporation
    • 11.2.7.Rain Oncology Inc.
    • 11.2.8.Strata Oncology, Inc.
    • 11.2.9.Xilis, Inc.
    • 11.2.10.Variantyx, Inc.
    • 11.2.11.Bioserve
    • 11.2.12.Relay Therapeutics
    • 11.2.13.Acrivon Therapeutics
    • 11.2.14.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Precision Oncology Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Precision Oncology Market, by Product Type 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: Indication Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication Type
  • TABLE Global Precision Oncology Market, by Indication Type 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: End-Use Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Precision Oncology Market, by End-Use 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Precision Oncology Market, by Region 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by End-Use, 2019-2032 (USD Million)

List of Figures

  • FIGURE Precision Oncology Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication Type segment market share analysis, 2023 & 2032
  • FIGURE Indication Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-Use segment market share analysis, 2023 & 2032
  • FIGURE End-Use segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Precision Oncology Market share and leading players, 2023
  • FIGURE Europe Precision Oncology Market share and leading players, 2023
  • FIGURE Asia Pacific Precision Oncology Market share and leading players, 2023
  • FIGURE Latin America Precision Oncology Market share and leading players, 2023
  • FIGURE Middle East and Africa Precision Oncology Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Precision Oncology Market share analysis by country, 2023
  • FIGURE Germany Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Precision Oncology Market share analysis by country, 2023
  • FIGURE India Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Precision Oncology Market share analysis by country, 2023
  • FIGURE Brazil Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Precision Oncology Market share analysis by country, 2023
  • FIGURE Saudi Arabia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)